Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Wall Street
Price Targets
REC Price Targets Summary
Recordati Industria Chimica e Farmaceutica SpA
According to Wall Street analysts, the average 1-year price target for REC is 53.08 EUR with a low forecast of 43.43 EUR and a high forecast of 65.1 EUR.
Price Targets
Revenue
Forecast
Revenue Estimate
Recordati Industria Chimica e Farmaceutica SpA
For the last 8 years the compound annual growth rate for Recordati Industria Chimica e Farmaceutica SpA's revenue is 9%. The projected CAGR for the next 3 years is 7%.
Operating Income
Forecast
Operating Income Estimate
Recordati Industria Chimica e Farmaceutica SpA
For the last 8 years the compound annual growth rate for Recordati Industria Chimica e Farmaceutica SpA's operating income is 9%. The projected CAGR for the next 3 years is 11%.
Net Income
Forecast
Net Income Estimate
Recordati Industria Chimica e Farmaceutica SpA
For the last 8 years the compound annual growth rate for Recordati Industria Chimica e Farmaceutica SpA's net income is 9%. The projected CAGR for the next 3 years is 15%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is REC's stock price target?
Price Target
53.08
EUR
According to Wall Street analysts, the average 1-year price target for REC is 53.08 EUR with a low forecast of 43.43 EUR and a high forecast of 65.1 EUR.
What is Recordati Industria Chimica e Farmaceutica SpA's Revenue forecast?
Projected CAGR
7%
For the last 8 years the compound annual growth rate for Recordati Industria Chimica e Farmaceutica SpA's revenue is 9%. The projected CAGR for the next 3 years is 7%.
What is Recordati Industria Chimica e Farmaceutica SpA's Operating Income forecast?
Projected CAGR
11%
For the last 8 years the compound annual growth rate for Recordati Industria Chimica e Farmaceutica SpA's operating income is 9%. The projected CAGR for the next 3 years is 11%.
What is Recordati Industria Chimica e Farmaceutica SpA's Net Income forecast?
Projected CAGR
15%
For the last 8 years the compound annual growth rate for Recordati Industria Chimica e Farmaceutica SpA's net income is 9%. The projected CAGR for the next 3 years is 15%.